PFE - PFE ファイザ― （）

A syringe is checked prior to a booster vaccine by a Nomi Health worker in West Valley City on July 14, 2022. Jeffrey D. Allred, Deseret News The new omicron-targeted COVID-19 booster shots may be shipping Friday, but aren’t expected to be widely available until after the Labor Day holiday. The first updated COVID-19 booster doses — also known as “bivalent vaccines” — from Pfizer and Moderna won quick approval this week from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention to be ready for another potential COVID-19 surge this fall. Related Forget herd immunity. Best case may be ‘herd safety,’ new COVID-19 study suggests Here’s what you need to know: Who can get an omicron booster shot? Teens and adults who have been fully vaccinated for at least two months. Fully vaccinated means having received the first two doses of the original Pfizer or Moderna vaccine, or the recently approved Novavax vaccine , or the single dose of the Johnson & Johnson vaccine that’s no longer recommended for most people Teens and adults who have waited at least two months since their most recent booster shot Pfizer’s omicron booster is authorized for people 12 and older Modern’s omicron booster is authorized for people 18 and older Related Will Novavax be the ‘perfect option’ for those still unvaccinated against COVID-19?

The CDC green-lighted updated Covid booster shots from Pfizer with BioNTech and Moderna, but vaccine stocks dipped Friday.

On August 26, 2022, biotechnology company Moderna filed lawsuits against pharmaceutical giant Pfizer and its German partner BioNTech for the alleged infringement of patented mRNA technology in the development of the "Comirnaty" COVID-19 vaccine.

A landmark peer-reviewed study appears to be the first of its kind to provide hard data on the “excess risk” of adverse […]

Forget Elon Musk vs. Twitter, there’s new beef on Wall Street. Back in 2020, as Covid-19 brought the world to a virtual standstill, pharma companies were focused on…

Watch Video Millions of COVID-19 vaccine doses have been ordered for small children in anticipation of possible federal authorization next week, White House officials say. The government allowed pharmacies and states to start placing orders last week, with 5 million doses initially available — half of them shots made by Pfizer and the other half the vaccine produced by Moderna, senior administration officials said. SEE MORE: FDA Advisers Back Novavax Vaccine As New U.S. Option As of this week, about 1.45 million of the 2.5 million available doses of Pfizer have been ordered, and about 850,000 of available Moderna shots have been ordered, officials said. More orders are expected in the coming days. Young children are the last group of Americans who have not been recommended to get COVID-19 vaccinations. Up to about 20 million U.S. children under 5 would become eligible for vaccination if the government authorizes one or both shots. It’s not clear how popular the shots will be. A recent survey suggests only 1 in 5 parents of young children would get their kids vaccinated right away.

Reuters Blackstone Closes In Crown Bid After Australia Approvals: Reuters Blackstone Inc (NYSE: BX ), the investment management company, is likely to take the reins of Australia’s Crown resorts after the country’s regulators approve the bid. The Blackstone - Crown Resorts Ltd buyout is expected to be about $6.3 billion. United States Helps To Keep Taiwanese Warships In Service The U.S. has cleared a possible $120 million sale of parts to assist Taiwan in maintaining its warships, which the island’s defense ministry said would help assure combat readiness in the face of China’s “frequent activities” near the island. The U. S. Defense Security Cooperation Agency stated that it had submitted the requisite certification to Congress following State Department approval for the sale, which was requested by Taiwan’s de facto embassy in Washington. State Street Might Tap Credit Suisse As Takeover Interest Credit Suisse Group AG (NYSE: CS ) could receive a takeover offer from U.S. financial giant State Street (NYSE: STT ), stated a media report a day earlier.

US stock futures traded mixed this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision. Below is a look at a few recent notable insider sales. For more, check out Benzinga''s insider transactions platform. Williams-Sonoma The Trade: Williams-Sonoma, Inc. (NYSE: WSM ) President WS Brand Ryan Ross sold a total of 10,400 shares at an average price of $127.42. The insider received around $1.33 million from selling those shares. What’s Happening: Morgan Stanley recently maintained Williams-Sonoma with … Full story available on Benzinga.com

The White House is announcing a Covid-19 vaccine rollout plan Thursday for children under 5, partnering with state and local governments, health care providers, federal pharmacy partners, national and community-based organizations and other entities to ship and distribute vaccines across the country following next week''s meeting of the FDA''s vaccine advisers -- who will review data on these vaccines from Pfizer and Moderna -- and expected authorization from the full FDA.

Vaccinations could begin later in June if shots from Moderna and Pfizer are authorized by the Food and Drug Administration.

Regional leaders from Pfizer in Africa and the Middle East region (AfME) has announced plans on delivering breakthroughs to more patients across the region, aiming to impact over 45 percent people in 2022. “As we continue to raise the bar within science and patient impact in the region, we are seeking even stronger collaborations with […]

Pfizer Covid shots, sparkling clean streets and tax-free policies are among the draws. And for investors with US$2.7 million to spare, there are ‘Golden Visas’, too.

Intranasal sprays might be more effective than jabs.

About 100,000 doses of Pfizer’s COVID-19 vaccine may be destroyed by the end of this month (March). This is due to the dwindling interest in patronage on the part of citizens, South African (SA) health authorities said on Friday.

The European Medicines Agency''s ((EMA)) leading vaccine expert Marco Cavaleri played down the impact of recent findings in New York over the decline of protection generated by…